ALLIANCEBERNSTEIN L.P. - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$136,900
+66.7%
74,0000.0%0.00%
Q4 2022$82,140
-48.0%
74,000
+9.5%
0.00%
Q3 2022$158,000
-19.8%
67,600
+3.8%
0.00%
Q2 2022$197,000
-53.3%
65,100
+4.8%
0.00%
Q1 2022$422,000
-18.4%
62,100
+0.3%
0.00%
Q4 2021$517,000
+12.4%
61,9000.0%0.00%
Q3 2021$460,000
+9.3%
61,9000.0%0.00%
Q2 2021$421,000
-26.7%
61,900
+10.7%
0.00%
Q1 2021$574,000
+46.8%
55,9000.0%0.00%
Q4 2020$391,000
-14.3%
55,9000.0%0.00%
Q3 2020$456,000
+16.9%
55,900
-1.1%
0.00%
Q2 2020$390,000
+63.9%
56,500
+12.5%
0.00%
Q1 2020$238,000
-35.3%
50,200
+19.2%
0.00%
Q4 2019$368,000
+162.9%
42,1000.0%0.00%
Q3 2019$140,000
-32.7%
42,1000.0%0.00%
Q2 2019$208,000
-18.8%
42,100
+1.9%
0.00%
Q1 2019$256,000
+84.2%
41,3000.0%0.00%
Q4 2018$139,000
-48.1%
41,3000.0%0.00%
Q3 2018$268,000
-11.8%
41,300
+4.0%
0.00%
Q2 2018$304,000
-23.6%
39,700
+123.0%
0.00%
Q1 2018$398,000
+130.1%
17,800
+30.9%
0.00%
Q4 2017$173,000
-11.7%
13,600
+7.9%
0.00%
Q3 2017$196,000
+10.7%
12,6000.0%0.00%
Q2 2017$177,00012,6000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 1,347,829$9,152,00093.42%
Ally Bridge Group (NY) LLC 550,000$3,735,0002.77%
ACUTA CAPITAL PARTNERS, LLC 813,500$5,524,0002.58%
TRV GP III, LLC 1,148,780$7,800,0002.12%
Deep Track Capital, LP 4,259,653$28,923,0001.86%
Logos Global Management LP 1,400,000$9,506,0001.23%
PFM Health Sciences, LP 3,972,868$26,976,0001.01%
Sofinnova Investments, Inc. 1,481,219$10,057,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 248,347$1,686,0000.70%
RTW INVESTMENTS, LP 4,680,412$31,780,0000.66%
View complete list of JOUNCE THERAPEUTICS INC shareholders